Abstract

Lung cancer is usually diagnosed at an advanced stage and survival has not improved in spite of several therapeutic advancements. Since most patients depend on palliative care, it is imperative to evaluate and maintain a satisfactory quality of life in them. Several questionnaires, mostly in western languages, have been used for this purpose. However, Indian data on this aspect is sparse. A 26-item WHO-Quality of Life questionnaire in local language was used to assess the quality of life in lung cancer patients attending a Tertiary care hospital. This questionnaire comprises four domains-Physical, Psychological, Social and Environmental. A total of 76 patients were evaluated. 66 (86.8%) were males, had a mean age of 55.36 years; presented with cough (82.9%), dyspnea (72.4%), chest pain (65.8%), and hemoptysis (43.4%). Eight patients (10.5%) had superior venacaval obstruction. The mean duration of symptoms was 5.9 months. 89.5% had Non-Small Cell Cancer (NSCLC). The mean pack-years was 23.7. Most patients had Karnofsky Performance Scale (KPS) of 70 (52.6%).There was no significant correlation of any quality of life domain with age, sex, duration of symptoms, extent of smoking, cough, dyspnea, chest pain, hemoptysis or hemoglobin. The environmental domain correlated significantly with the serum albumin (p<0.016). The physical domain scores of patients with KPS of 80% correlated significantly with those having KPS of 70% and 60% (p < 0.001 and p < 0.003 respectively). The psychological domain scores of patients with KPS 80% correlated significantly with those having KPS 70% (p < 0.005). Quality of life in lung cancer is not affected by age, sex, presence of symptoms and their duration or extent of smoking. Karnofsky Performance Scale is a useful surrogate marker of quality of life in these patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call